He reported no financial conflicts of interest regarding his study.
Simultaneously with Dr. Xaplanteris’ presentation of the final 5-year outcomes of FAME 2, the results were published online (N Engl J Med. 2018 May 22. doi: 10.1056/NEJMoa1803538). He reported having no financial conflicts of interest.
Similarly, Dr. Al-Lamee’s updated analysis of ORBITA was simultaneously published (Circulation. 2018 May 22. doi: 10.11161/CIRCULATIONAHA.118.033801). She, too, reported having no financial conflicts regarding this investigator-initiated study.
Dr. Haude expressed confidence that these studies will result in significant changes in the next iteration of the European Society of Cardiology guidelines on chronic coronary syndrome, likely to be issued in 2019 or 2020.